SCHEMBL27604697

SCHEMBL27604697

O=C(c1ccccc1)c1ccc([N+](=O)[O-])cc1[SH](=O)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.54
LMNA P02545 3/20 0.53
POLB P06746 3/20 0.53
HTT P42858 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
MAPT P10636 2/20 0.53
ALDH1A1 P00352 6/20 0.50
GAA P10253 2/20 0.50
MAPK1 P28482 2/20 0.49
CES1 P23141 2/20 0.49
MAPK14 Q16539 1/20 0.48
TP53 P04637 1/20 0.47
CYP19A1 P11511 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
CYP3A4 P08684 2/20 0.45
ALOX15 P16050 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
SRD5A2 P31213 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27589010 0.83 ALDH1A1 (0.60) CES2HTTSMN1; SMN2MAPTALDH1A1
SCHEMBL27497022 0.80 GAA (0.60) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL29355334 0.80 CES2 (0.75) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL5313439 0.80 MAPT (0.60) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL11230405 0.80 CES2 (0.75) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL11010668 0.80 LMNA (0.60) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL2923533 0.79 ALDH1A1 (0.69) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL6314599 0.79 MAPK1 (0.68) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL27405553 0.79 ALDH1A1 (0.56) CES2LMNAPOLBHTTSMN1; SMN2
SCHEMBL14744336 0.79 CES2 (0.56) CES2LMNAPOLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108084246-A The high penetrating power prodrugs composition of polypeptide and polypeptide related compound 上海泰飞尔生化技术有限公司 2018-05-29 CN disclosed
CN-100563653-C Has the active heterocyclic compound of beta-lactamase inhibitor AVENTIS PHARMA SA (FR) 2009-12-02 CN disclosed
CN-100482225-C Novel heterocyclic compounds having beta-lactamase inhibitor activity AVENTIS PHARMA SA (FR) 2009-04-29 CN disclosed
CN-101406471-A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases AVENTIS PHARMA SA (FR) 2009-04-15 CN disclosed
CN-1994301-A Heterocyclic compounds which are active as inhibitors of beta lactamases AVENTIS PHARMA SA (FR) 2007-07-11 CN disclosed
CN-1655781-A Novel heterocyclic compounds having beta-lactamase inhibitor activity AVENTIS PHARMA SA (FR) 2005-08-17 CN disclosed